{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:08:17Z","timestamp":1764922097099,"version":"3.46.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/14740338.2024.2418333","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:37:07Z","timestamp":1729215427000},"page":"1443-1451","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of adverse events of poly adenosine diphosphate ribose polymerase inhibitors in patients with ovarian cancer using the United States Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-5349","authenticated-orcid":false,"given":"Toru","family":"Ogura","sequence":"first","affiliation":[{"name":"Mie University Hospital","place":["Tsu, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-6540","authenticated-orcid":false,"given":"Chihiro","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Mie University Hospital","place":["Tsu, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0345-6"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16231"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2020.00011"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0752-y"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0716-2"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0027-5107(01)00111-7"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102021"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230209121732"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01167-6"},{"key":"e_1_3_7_12_1","unstructured":"Olaparib side effects [Internet]. New Zealand: Drugs.com; [cited 2024 May 4: Available from: https:\/\/www.drugs.com\/sfx\/olaparib-side-effects.html"},{"key":"e_1_3_7_13_1","unstructured":"Niraparib side effects [Internet]. New Zealand: Drugs.com; [cited 2024 May 4: Available from: https:\/\/www.drugs.com\/sfx\/niraparib-side-effects.html"},{"key":"e_1_3_7_14_1","unstructured":"Rucaparib side effects [Internet]. New Zealand: Drugs.com; [cited 2024 May 4: Available from: https:\/\/www.drugs.com\/sfx\/rucaparib-side-effects.html"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.11.037"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2022.2154940"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02569-3"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad171"},{"key":"e_1_3_7_19_1","unstructured":"FDA Adverse Event Reporting System (FAERS) [Internet]. (MD) (MA): U.S. Food and Drug Administration; [cited 2024 May 4: Available from: https:\/\/fis.fda.gov\/extensions\/FPD-QDE-FAERS\/FPD-QDE-FAERS.html"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-022-01242-7"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101900"},{"key":"e_1_3_7_22_1","unstructured":"R Core Team. R: a language and environment for statistical computing. Version 4.2.2 [software]. R Foundation for Statistical Computing. [cited 2024 May 4: Available from: https:\/\/www.R-project.org\/"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.851246"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.968163"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(200001\/02)9:1<37::AID-PDS471>3.0.CO;2-U"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S147726"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.06.012"},{"issue":"5","key":"e_1_3_7_28_1","first-page":"405","article-title":"High prevalence of drug-induced pneumonia in Japan","volume":"50","author":"Azuma A","year":"2007","unstructured":"Azuma A, Kudoh S. High prevalence of drug-induced pneumonia in Japan. Jpn Med Assoc J. 2007;50(5):405\u2013411.","journal-title":"Jpn Med Assoc J"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265769"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.10.005"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.11.024"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241233225"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000001024"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e104"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2418333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:04:38Z","timestamp":1764921878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2418333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/14740338.2024.2418333"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2418333","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}